KELOIDS AND HYPERTROPHIC SCARS: RESULTS WITH INTRA‐OPERATIVE AND SERIAL POSTOPERATIVE CORTICOSTEROID INJECTION THERAPY
Nisar Ahmad Chowdri, Mohammad Masarat Ajaz Mattoo, Mohammad Ashraf Darzi
Abstract
Open-access reader
Nisar Ahmad Chowdri, Mohammad Masarat Ajaz Mattoo, Mohammad Ashraf Darzi
Abstract
Open-access reader
BACKGROUND: The management of keloids and hypertrophic scars continues to be controversial. Experience of treating 58 such lesions, 58.62% of which were recurrent, is presented. METHODS: Each lesion was subjected to surgical excision with intra-operative local injection of triamcinolone acetonide, followed by repeat injection of the same drug at weekly intervals for 2-5 weeks depending on the symptomatic relief, and then monthly injections for 4-6 months. RESULTS: Complete symptomatic relief was achieved in all patients within 5 weeks of surgery. Objective response in terms of no recurrence was noted in 91.9% of patients with keloids, and 95.24% of patients with hypertrophic scars at a mean follow-up of 30.5 months. Local or systemic complications were insignificant. CONCLUSION: Because of promising results, further use and evaluation of this method of treatment is recommended for large, recurrent and complicated keloids and hypertrophic scars.
OpenAlex reports 120 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
BACKGROUND: The management of keloids and hypertrophic scars continues to be controversial. Experience of treating 58 such lesions, 58.62% of which were recurrent, is presented. METHODS: Each lesion was subjected to surgical excision with intra-operative local injection of triamcinolone acetonide, followed by repeat injection of the same drug at weekly intervals for 2-5 weeks depending on the symptomatic relief, and then monthly injections for 4-6 months. RESULTS: Complete symptomatic relief was achieved in all patients within 5 weeks of surgery. Objective response in terms of no recurrence was noted in 91.9% of patients with keloids, and 95.24% of patients with hypertrophic scars at a mean follow-up of 30.5 months. Local or systemic complications were insignificant. CONCLUSION: Because of promising results, further use and evaluation of this method of treatment is recommended for large, recurrent and complicated keloids and hypertrophic scars.
Key concepts: Medicine, Triamcinolone acetonide, Hypertrophic scars, Hypertrophic scar, Surgery, Scars, Corticosteroid, Lesion